Meet us at PharmaSynergy 

Our Head of Business Development at Adragos Athens, Erato Zogana, will be attending the Pharma Synergy event on February 8th and 9th in London. Looking for the opportunity to engage and network with professionals in the pharmaceutical community to discuss developments and licensing services.

Adragos significantly invests in Japanese Kawagoe’s Plant

Read about Adragos’ plans and growth predictions in Kawagoe City, Japan. Adragos aims to make significant investments in the Japanese pharmaceutical contract manufacturing industry, as reported by Nikkei. Find the complete article below! Adragos significantly invests in Japanese Kawagoe’s Plant Adragos Pharma, a CDMO headquartered in Munich, Germany, plans to invest significantly in the Japanese […]

Meet us at PharmaVenue 2024

Adragos Pharma’s Business Development Team, Erato Zogana, and Christina Yfanti are looking forward to attending important networking and partnering event at PharmaVenue on January 22nd and 23rd, 2024, in Barcelona. We look forward to seeing you there. 

Adragos’ CEO takes the stage at J.P. Morgan Healthcare Conference

Andreas Raabe, Adragos’ Chief Executive Officer, will be participating in the 42nd annual J.P. Morgan Healthcare Conference on Thursday, 11th of January at 10 am PST, providing an overview of Adragos Pharma’s priorities and the company’s progress to date. This event brings together industry leaders, investors, and professionals to discuss the latest trends and explore […]

Join Adragos Pharma at CPHI Barcelona 2023 – October 24-26

Dear Valued Partners and Industry Enthusiasts, We are thrilled to announce that the Adragos Pharma team will be participating in one of the pharmaceutical industry’s most prestigious events – CPHI Worldwide 2023, taking place in beautiful Barcelona from October 24th to 26th. Our presence at CPHI Barcelona is a testament to our dedication to excellence […]

Adragos Pharma Announces Divestiture of Toride Pharma K.K. and Toride Asset Trading Co. Ltd.

Munich, Germany / Tokyo, Japan, June 15, 2023 — Adragos Pharma GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the divestiture of its subsidiary Toride Pharma K.K., and its associated entity, Toride Asset Trading Co. Ltd. to Fuji Seal, Inc. This divestiture exemplifies Adragos Pharma’s proactive network management strategy. “Strategically, […]